Fate Therapeutics
Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Market cap
$119m
Enterprise value
($38m)
Share price
$1.12 FATE
loading funding rounds…
Silicon Valley Bank(exited)
OVP Venture Partners(exited)
ARCH Venture Partners(exited)
Venrock(exited)
Polaris Partners(exited)
Astellas Venture(exited)
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 15 % | 125 % | 194 % | 78 % | 72 % | (34 %) | (79 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (1344 %) | (903 %) | (400 %) | (386 %) | (320 %) | (275 %) | (1193 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1405 %) | (919 %) | (552 %) | (380 %) | (293 %) | (253 %) | (1366 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 1182 % | 822 % | 400 % | 386 % | 333 % | 272 % | 990 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.